Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
41.87B | 40.30B | 38.81B | 40.14B | 40.46B | Gross Profit |
9.48B | 9.32B | 9.22B | 8.80B | 8.78B | EBIT |
2.03B | 2.26B | 2.30B | 2.00B | 1.80B | EBITDA |
5.27B | 5.46B | 5.67B | 5.40B | 4.30B | Net Income Common Stockholders |
1.63B | 1.71B | 1.78B | 1.64B | 1.49B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
8.94B | 10.85B | 14.73B | 7.55B | 6.27B | Total Assets |
68.70B | 65.14B | 69.23B | 63.56B | 61.82B | Total Debt |
20.06B | 18.72B | 23.86B | 19.36B | 17.42B | Net Debt |
11.12B | 7.86B | 9.13B | 11.81B | 11.15B | Total Liabilities |
34.53B | 32.31B | 37.58B | 32.14B | 31.57B | Stockholders Equity |
33.05B | 32.50B | 31.34B | 31.00B | 29.83B |
Cash Flow | Free Cash Flow | |||
650.17M | 1.95B | 3.73B | 108.64M | -3.64B | Operating Cash Flow |
3.55B | 4.58B | 4.57B | 4.47B | 2.50B | Investing Cash Flow |
-4.96B | -2.38B | -840.19M | -4.33B | -6.22B | Financing Cash Flow |
-474.94M | -6.05B | 3.45B | 1.14B | 4.32B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
72 Outperform | ¥34.31B | 11.67 | 3.34% | 4.35% | 35.34% | ||
68 Neutral | €61.45B | 15.40 | 3.29% | 4.09% | 16.62% | ― | |
67 Neutral | $1.19T | 13.56 | 6.28% | 1.09% | 4.88% | 77.54% | |
67 Neutral | ¥18.66B | 10.82 | 4.39% | 2.46% | 17.72% | ||
67 Neutral | $981.32B | 7.29 | 10.80% | 1.79% | 2.25% | 17.40% | |
61 Neutral | $6.59B | 11.77 | 3.06% | 3.98% | 2.56% | -20.85% | |
54 Neutral | ¥3.99B | ― | 3.84% | -0.03% | -109.88% |